JP2015537023A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015537023A5 JP2015537023A5 JP2015542309A JP2015542309A JP2015537023A5 JP 2015537023 A5 JP2015537023 A5 JP 2015537023A5 JP 2015542309 A JP2015542309 A JP 2015542309A JP 2015542309 A JP2015542309 A JP 2015542309A JP 2015537023 A5 JP2015537023 A5 JP 2015537023A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- saquinavir
- nitrate
- autoimmune
- uveitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261728330P | 2012-11-20 | 2012-11-20 | |
| US61/728,330 | 2012-11-20 | ||
| PCT/EP2013/074264 WO2014079868A1 (en) | 2012-11-20 | 2013-11-20 | Saquinavir-no for immunomodulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015537023A JP2015537023A (ja) | 2015-12-24 |
| JP2015537023A5 true JP2015537023A5 (enExample) | 2017-01-05 |
| JP6283680B2 JP6283680B2 (ja) | 2018-02-21 |
Family
ID=49759262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542309A Expired - Fee Related JP6283680B2 (ja) | 2012-11-20 | 2013-11-20 | サキナビル−ｎｏの免疫調節効果 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150283127A1 (enExample) |
| EP (1) | EP2922545B1 (enExample) |
| JP (1) | JP6283680B2 (enExample) |
| KR (1) | KR20150084862A (enExample) |
| CN (1) | CN104822379B (enExample) |
| AU (1) | AU2013349804A1 (enExample) |
| BR (1) | BR112015011299A2 (enExample) |
| CA (1) | CA2891771A1 (enExample) |
| IL (1) | IL238866A0 (enExample) |
| MX (1) | MX2015006249A (enExample) |
| WO (1) | WO2014079868A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104127858A (zh) * | 2014-07-26 | 2014-11-05 | 滨州医学院 | 甲磺酸沙奎拉韦在制备预防或治疗内毒素血症和脓毒症的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605289B1 (en) * | 1998-06-09 | 2003-08-12 | Embro Research Company, Llc. | Method and composition for the treatment of epidermal irritations and infections |
| FR2779653B1 (fr) * | 1998-06-11 | 2002-12-20 | Inst Nat Sante Rech Med | Utilisation de composes modulateurs du proteasome en therapie |
| AU2002346594A1 (en) * | 2001-12-14 | 2003-06-30 | Cedars-Sinai Medical Center | Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation |
| PL2306995T3 (pl) * | 2008-08-01 | 2014-12-31 | Onconox Aps | Właściwości przeciwnowotworowe inhibitorów proteazy zmodyfikowanych NO |
| CN103347539A (zh) * | 2010-12-22 | 2013-10-09 | 范斯坦医药研究院 | 使用hiv蛋白酶抑制剂治疗系统性红斑狼疮的方法 |
-
2013
- 2013-11-20 US US14/443,402 patent/US20150283127A1/en not_active Abandoned
- 2013-11-20 AU AU2013349804A patent/AU2013349804A1/en not_active Abandoned
- 2013-11-20 BR BR112015011299A patent/BR112015011299A2/pt not_active IP Right Cessation
- 2013-11-20 KR KR1020157013049A patent/KR20150084862A/ko not_active Withdrawn
- 2013-11-20 WO PCT/EP2013/074264 patent/WO2014079868A1/en not_active Ceased
- 2013-11-20 JP JP2015542309A patent/JP6283680B2/ja not_active Expired - Fee Related
- 2013-11-20 CA CA2891771A patent/CA2891771A1/en not_active Abandoned
- 2013-11-20 EP EP13802901.2A patent/EP2922545B1/en not_active Not-in-force
- 2013-11-20 CN CN201380060071.4A patent/CN104822379B/zh not_active Expired - Fee Related
- 2013-11-20 MX MX2015006249A patent/MX2015006249A/es unknown
-
2015
- 2015-05-18 IL IL238866A patent/IL238866A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201903474PA (en) | New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs | |
| JP2017105793A5 (enExample) | ||
| JP2016147915A5 (enExample) | ||
| JP2015527401A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| RU2015117251A (ru) | Новые соединения | |
| JO3377B1 (ar) | مشتقات بيريدينيل وبيريدينيل مندمج | |
| TN2015000348A1 (en) | Antibodies that bind il-23 | |
| MX354423B (es) | Formulaciones de rasagilina de liberación prolongada y usos de las mismas. | |
| JP2015532296A5 (enExample) | ||
| JP2013533883A5 (enExample) | ||
| JP2016509051A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| MA38668A1 (fr) | Cristal stabilisé de chlorhydrate de tipiracil, et son procédé de cristallisation | |
| JP2016510768A5 (enExample) | ||
| JPWO2021111124A5 (enExample) | ||
| CN110382463A (zh) | Hdac6选择性抑制剂及其制备方法和应用 | |
| JP2015516419A5 (enExample) | ||
| RU2015135824A (ru) | Бициклические соединения пиримидона в качестве ингибиторов lp-pla2 | |
| JP2019052094A5 (enExample) | ||
| JP2015537023A5 (enExample) | ||
| HRP20200001T1 (hr) | Kristalični oblik spoja (s)-3-{4-[5-(2-ciklopentil-6-metoksi-piridin-4-il)-[1,2,4]oksadiazol-3-il]-2-etil-6-metil-fenoksi}-propan-1,2-diol | |
| HRP20241042T1 (hr) | Novi analozi inzulina i njihova upotreba | |
| JP2016523943A5 (enExample) |